SOLOTHERA Trademark

Trademark Overview

On Tuesday, February 21, 2023, a trademark application was filed for SOLOTHERA with the United States Patent and Trademark Office. The USPTO has given the SOLOTHERA trademark a serial number of 97804269. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Friday, November 22, 2024. This trademark is owned by Loft Labs LLC. The SOLOTHERA trademark is filed in the Medical Instrument Products category with the following description:

Drug delivery devices sold empty, namely, inhalers for medical purposes

General Information

Serial Number97804269
Word MarkSOLOTHERA
Filing DateTuesday, February 21, 2023
Status730 - FIRST EXTENSION - GRANTED
Status DateFriday, November 22, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 9, 2024

Trademark Statements

Goods and ServicesDrug delivery devices sold empty, namely, inhalers for medical purposes

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateSunday, March 12, 2023
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameLoft Labs LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressNew York, NY 10001
Party NameLoft Labs LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressNew York, NY 10001

Trademark Events

Event DateEvent Description
Friday, February 24, 2023NEW APPLICATION ENTERED
Sunday, March 12, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sunday, November 19, 2023ASSIGNED TO EXAMINER
Tuesday, November 28, 2023NON-FINAL ACTION WRITTEN
Tuesday, November 28, 2023NON-FINAL ACTION E-MAILED
Tuesday, November 28, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, February 27, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 27, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 27, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, February 28, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 28, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 28, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, March 5, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 20, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 9, 2024PUBLISHED FOR OPPOSITION
Tuesday, April 9, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 4, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 19, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 19, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 19, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, November 19, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, November 22, 2024SOU TEAS EXTENSION RECEIVED
Saturday, November 23, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, November 23, 2024SOU EXTENSION 1 FILED
Saturday, November 23, 2024SOU EXTENSION 1 GRANTED

Related Keywords

solothera inhalers medical purposes namely empty delivery devices sold drug